A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer
10.1007/s10549-013-2495-0
Saved in:
Main Authors: | Tan, P.S., Haaland, B., Montero, A.J., Lopes, G. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/124658 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations
by: Haaland, B., et al.
Published: (2016) -
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis
by: Ridouane, Y, et al.
Published: (2020) -
Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
by: Tan, P.S, et al.
Published: (2020) -
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore
by: Shih, V., et al.
Published: (2014) -
Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials
by: Ku, G.Y., et al.
Published: (2016)